Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Hypertension. 2015 Mar 2;65(5):1064–1072. doi: 10.1161/HYPERTENSIONAHA.115.05255

Figure 5.

Figure 5

SKF38393-induced inhibition of Na/K-ATPase activity in HK2 cells and rat renal proximal tubules. A representative dose response curve of SKF38393-induced inhibition of Na/K-ATPase activity in control (C), L-buthionine sulfoximine (BSO), tempol (T) and BSO + tempol treated HK2 cells (A). SKF3893-induced (1 µmol/L) inhibition of Na/K-ATPase activity in HK2 cells (B) and renal proximal tubules (C). Experiments were performed in triplicate and data represents Mean ± SE from 4–6 cell passages (cells from passage 2–8) or 5–7 rats in each group. *P<0.05 vs. basal.